<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2007-11-18" updated="2020-01-02">
  <drugbank-id primary="true">DB05276</drugbank-id>
  <name>Hepatitis B Immune Globulin</name>
  <description>Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. Therefore, the hepatitis-B vaccines are cancer-preventing vaccines. According to the Centers for Disease Control and Prevention (CDC), the hepatitis B vaccine was the first anti-cancer vaccine.&#13;
&#13;
HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen. It is extracted from the Cohn fraction II. During the process, viruses are deactivated, and in the final steps, solvents used in the preparation are removed. The preparation is tested for absence of HIV, HCV, herpes virus, and reovirus.</description>
  <cas-number/>
  <unii>XII270YC6M</unii>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A3336</ref-id>
        <pubmed-id>9425940</pubmed-id>
        <citation>Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS: Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology. 1998 Jan;27(1):213-22.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Investigated for use/treatment in hepatitis (viral, B), liver transplant surgery, and pediatric indications.</indication>
  <pharmacodynamics/>
  <mechanism-of-action>In countries with high rates of hepatitis B infection, vaccination of newborns has not only reduced the risk of infection, but has also led to marked reduction in liver cancer.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">HBIG</synonym>
    <synonym language="english" coder="">Hepatitis B Immune Globulin (Human)</synonym>
    <synonym language="english" coder="">Hepatitis B immune globulin human</synonym>
    <synonym language="english" coder="">Hepatitis B immunoglobulin (human)</synonym>
    <synonym language="english" coder="">Human hepatitis B immunoglobulin</synonym>
    <synonym language="english" coder="">Human hepatitis B virus immune globulin</synonym>
    <synonym language="english" coder="">Human hepatitis-B immunoglobulin</synonym>
  </synonyms>
  <products>
    <product>
      <name>H-big</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00780251</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-18</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Aptevo Biotherapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70504-0053</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Aptevo Biotherapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70504-0054</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Cangene BioPharma, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>53270-0053</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>50 mg/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Cangene BioPharma, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>53270-0054</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>50 mg/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Saol Therapeutics Research Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02290979</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-08-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>312 unit</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Saol Therapeutics Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>70257-052</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Saol Therapeutics Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>70257-051</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Cangene Bio Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>53270-0052</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Cangene Bio Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>53270-0051</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Apotex Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>60505-6071</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-01</started-marketing-on>
      <ended-marketing-on>2012-12-31</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Apotex Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>60505-6072</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-01</started-marketing-on>
      <ended-marketing-on>2012-12-31</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Aptevo Biotherapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70504-0052</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepaGam B</name>
      <labeller>Aptevo Biotherapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70504-0051</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number>BLA125035</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hepatitis B Ig Inj</name>
      <labeller>Cutter Med &amp; Biol, Division Of Miles Canada Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00499617</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1998-09-25</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hyperhep B S/d</name>
      <labeller>GRIFOLS USA, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>13533-636</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-10-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>220 [iU]/1mL</strength>
      <route>Intramuscular</route>
      <fda-application-number>BLA101146</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hyperhep B S/d</name>
      <labeller>Grifols Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230738</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-07-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>220 unit</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hyperhep B S/d</name>
      <labeller>Grifols Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02379465</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>220 unit</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hyperhep B S/d</name>
      <labeller>Grifols Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02379473</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>220 unit</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Immunogam</name>
      <labeller>Cangene Europe Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001055</ema-product-code>
      <ema-ma-number>EU/1/10/613/001</ema-ma-number>
      <started-marketing-on>2010-03-16</started-marketing-on>
      <ended-marketing-on>2011-01-26</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 IU/ml</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Immunogam</name>
      <labeller>Cangene Europe Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001055</ema-product-code>
      <ema-ma-number>EU/1/10/613/002</ema-ma-number>
      <started-marketing-on>2010-03-16</started-marketing-on>
      <ended-marketing-on>2011-01-26</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>312 IU/ml</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Nabi-HB</name>
      <labeller>Adma Biologics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>69800-4202</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular</route>
      <fda-application-number>BLA103945</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nabi-HB</name>
      <labeller>Adma Biologics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>69800-4203</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1560 [iU]/5mL</strength>
      <route>Intramuscular</route>
      <fda-application-number>BLA103945</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nabi-HB</name>
      <labeller>ADMA Biologics, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>59730-4202</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-10</started-marketing-on>
      <ended-marketing-on>2021-12-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength>312 [iU]/1mL</strength>
      <route>Intramuscular</route>
      <fda-application-number>BLA103945</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nabi-HB</name>
      <labeller>ADMA Biologics, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>59730-4203</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-12</started-marketing-on>
      <ended-marketing-on>2022-09-30</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength>1560 [iU]/5mL</strength>
      <route>Intramuscular</route>
      <fda-application-number>BLA103945</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Immunogam</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Immunogam</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Hyperhep B S/d</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Nabi-HB</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Nabi-HB</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Nabi-HB</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Nabi-HB</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Hyperhep B S/d</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Hyperhep B S/d</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Hepatitis B Ig Inj</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>H-big</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>Hyperhep B S/d</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
    <mixture>
      <name>HepaGam B</name>
      <ingredients>Hepatitis B Immune Globulin</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Blood Proteins</category>
      <mesh-id>D001798</mesh-id>
    </category>
    <category>
      <category>Globulins</category>
      <mesh-id>D005916</mesh-id>
    </category>
    <category>
      <category>Human Immunoglobulin</category>
      <mesh-id/>
    </category>
    <category>
      <category>Immunization, Passive</category>
      <mesh-id>D007116</mesh-id>
    </category>
    <category>
      <category>Immunoproteins</category>
      <mesh-id>D007162</mesh-id>
    </category>
    <category>
      <category>Passively Acquired Immunity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
    <category>
      <category>Serum</category>
      <mesh-id>D044967</mesh-id>
    </category>
    <category>
      <category>Serum Globulins</category>
      <mesh-id>D012712</mesh-id>
    </category>
    <category>
      <category>Virus Neutralization</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular; Intravenous</route>
      <strength>312 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength>312 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength>50 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength>312 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength>312 unit</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular</route>
      <strength>220 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intramuscular</route>
      <strength>220 unit</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intramuscular</route>
      <strength>312 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular</route>
      <strength>1560 [iU]/5mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular</route>
      <strength>312 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intramuscular</route>
      <strength>1560 [iU]/5mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intramuscular</route>
      <strength>312 [iU]/1mL</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes>
    <ahfs-code>80:04.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>7764</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>22954</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347910055</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL2108512</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002427</id>
      <name>HBsAg</name>
      <organism>HBV</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q69600" source="TrEMBL">
        <name>HBsAg</name>
        <general-function/>
        <specific-function/>
        <gene-name>S gene</gene-name>
        <locus/>
        <cellular-location>Virion membrane</cellular-location>
        <transmembrane-regions>80-98
170-199
205-225</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>7.9</theoretical-pi>
        <molecular-weight>25420.905</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="10407">HBV</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X75668</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q69600</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q69600_HBV</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Major Surface Antigen</synonym>
          <synonym>S</synonym>
          <synonym>S protein</synonym>
          <synonym>sAg</synonym>
          <synonym>Small S protein</synonym>
          <synonym>Small surface antigen</synonym>
          <synonym>Surface antigen</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011738|HBsAg
MENITSGFLGPLLVLQAGFFLLTRILTIPQSLDSWWTSLNFLGGTTVCLGQNSQSPTSNH
SPTSCPPTCPGYRWMCLRRFIIFLFILLLCLIFLLVLLDYQGMLPVCPLIPGSSTTSTGP
CRTCMTTAQGTSMYPSCCCTKPSDGNCTCIPIPSSWAFGKFLWEWASARFSWLSLLVPFV
QWFVGLSPTVWLSVIWMMWYWGPSLYSILSPFLPLLPIFFCLWVYI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0004765|681 bp
ATGGAGAACATCACATCAGGATTCCTAGGACCCCTTCTCGTGTTACAGGCGGGGTTTTTC
TTGTTGACAAGAATCCTCACAATACCGCAGAGTCTAGACTCGTGGTGGACTTCTCTCAAT
TTTCTAGGGGGAACTACCGTGTGTCTTGGCCAAAATTCGCAGTCCCCAACCTCCAATCAC
TCACCAACCTCCTGTCCTCCAACTTGTCCTGGTTATCGCTGGATGTGTCTGCGGCGTTTT
ATCATCTTCCTCTTCATCCTGCTGCTATGCCTCATCTTCTTGTTGGTTCTTCTGGACTAT
CAAGGTATGTTGCCCGTTTGTCCTCTAATTCCAGGATCCTCAACCACCAGCACGGGACCA
TGCCGAACCTGCATGACAACTGCTCAAGGAACCTCTATGTATCCCTCCTGTTGCTGTACC
AAACCTTCGGACGGAAATTGCACCTGTATTCCCATCCCATCATCCTGGGCTTTCGGAAAA
TTCCTATGGGAGTGGGCCTCAGCCCGTTTCTCCTGGCTCAGTTTACTAGTGCCATTTGTT
CAGTGGTTCGTAGGGCTTTCCCCCACTGTTTGGCTTTCAGTTATATGGATGATGTGGTAT
TGGGGGCCAAGTCTGTACAGCATCTTGAGTCCCTTTTTACCGCTGTTACCAATTTTCTTT
TGTCTTTGGGTATACATTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00695</identifier>
            <name>vMSA</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>virion membrane</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>membrane fusion involved in viral entry into host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>virion attachment to host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>